Peter E. Andreotti

1.9k citations

37 papers · 1.6k indexed · h-index 21

Impact in

Oncology top 5%
Virology top 10%

Papers in ⓘ

Endocrinology 3
- Escherichia coli research studies 3
Immunology 7
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- Biosimilars and Bioanalytical Methods 3

Co-authors: Christian M. Kurbacher (9 shared papers)Ian A. Cree (12 shared papers)Peter Cresswell (3 shared papers)Howard W. Bruckner (8 shared papers)Dieter Krebs (3 shared papers)John Apgar (1 shared paper)Uwe Wagner (1 shared paper)I A Cree (2 shared papers)
Journals: Anti-Cancer Drugs (8 papers)Journal of Pharmaceutical Sciences (2 papers)The Journal of Immunology (2 papers)Human Immunology (2 papers)BMC Cancer (1 paper)
Partner nations: United States United Kingdom Germany

In The Last Decade

Peter E. Andreotti

37 papers receiving 1.5k citations

Peers

Countries citing papers authored by Peter E. Andreotti

Since Specialization

Citations

This map shows the geographic impact of Peter E. Andreotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Andreotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Andreotti more than expected).

Fields of papers citing papers by Peter E. Andreotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Andreotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Andreotti. The network helps show where Peter E. Andreotti may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter E. Andreotti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter E. Andreotti Line = papers co-authored together Peter E. Andreotti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. PubMed ·Peter E. Andreotti, I A Cree, Christian M. Kurbacher, Diana M. Hartmann, Dee Linder, Gal Harel, I Gleiberman, Paola Caruso, Sherianne Ricks, Michael Untch	1995	246
2	Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro Cancer Letters ·Christian M. Kurbacher, Uwe Wagner, Bernd Kolster, Peter E. Andreotti, Dieter Krebs, Howard W. Bruckner	1996	189
3	HLA-A2 as a target for cell-mediated lympholysis: Evidence from immunoselected HLA-A2 negative mutant cell lines Human Immunology ·Peter E. Andreotti, John Apgar, Peter Cresswell	1980	115
4	Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. The Journal of Immunology ·D N Howell, Peter E. Andreotti, J R Dawson, Peter Cresswell	1985	107
5	Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer Anti-Cancer Drugs ·Christian M. Kurbacher, Ian A. Cree, Howard W. Bruckner, Ursula Brenne, J.A. Kurbacher, Karin M ller, Tonja Ackermann, T. Gilster, Lucas M Wilhelm, Heike Engel, Peter Mallmann, Peter E. Andreotti	1998	105
6	Immunoassay of infectious agents BioTechniques ·Peter E. Andreotti, George V. Ludwig, Anne Harwood Peruski, James J. Tuite, Stephen S. Morse, Leonard F. Peruski	2003	92
7	Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines Toxicology in Vitro ·Ian A. Cree, Peter E. Andreotti	1997	76
8	Chemiluminescence: Principles and Applications in Biology and Medicine Journal of Pharmaceutical Sciences ·Peter E. Andreotti	1989	76
9	Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity Anti-Cancer Drugs ·Ian A. Cree, Christian M. Kurbacher, Michael Untch, Lesley Sutherland, Elizabeth M. Hunter, Andrea M C Subedi, Elizabeth A. James, John Dewar, P E Preece, Peter E. Andreotti, Howard W. Bruckner	1996	68
10	Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay. PubMed ·Elizabeth M. Hunter, L. Sutherland, I A Cree, J A Dewar, P E Preece, Robert A. Wood, D. J. Linder, Peter E. Andreotti	1993	48
11	Heterogeneity of chemosensitivity of metastatic cutaneous melanoma Anti-Cancer Drugs ·Ian A. Cree, Michael H. Neale, Nyree Myatt, Pippa G de Takats, Per Hall, J Grant, Christian M. Kurbacher, Uwe Reinhold, K. Neuber, Rona M. MacKie, Jagdeep S. Chana, P C Weaver, Ghassan Khoury, Christian Sartori, Peter E. Andreotti	1999	45
12	Expression of the p53 Tumor Suppressor Gene Product Is a Determinant of Chemosensitivity Biochemical and Biophysical Research Communications ·Robert Petty, Ian A. Cree, L. Sutherland, Eileen Hunter, David P. Lane, P.E. Preece, Peter E. Andreotti	1994	40
13	Enzyme-linked immunomagnetic chemiluminescent detection of Escherichia coli O157:H7 Journal of Immunological Methods ·Andrew Gehring, Peter L. Irwin, Sue Reed, Shu‐I Tu, Peter E. Andreotti, Hashem Akhavan-Tafti, R. Handley	2004	37
14	TCA‐100 tumour chemosensitivity assay: Differences in sensitivity between cultured tumour cell lines and clinical studies Journal of Bioluminescence and Chemiluminescence ·Peter E. Andreotti, Dee Linder, Diana M. Hartmann, Ian A. Cree, Mario Pazzagli, Howard W. Bruckner	1994	34
15	Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC) BMC Cancer ·Sharon Glaysher, Dennis Yiannakis, Francis G Gabriel, Penny Johnson, Marta E. Polak, Louise A. Knight, Zoe Goldthorpe, Katharine Peregrin, M.M. Gyi, Paul Modi, Joe Rahamim, Mark E. Smith, Khalid Amer, Bruce Addis, Matthew Poole, Ajit Narayanan, T. Gulliford, Peter E. Andreotti, Ian A. Cree	2009	33
16	Imaging of luciferase and GFP‐transfected human tumours in nude mice Luminescence ·Gisela Cáceres, Xiaoyun Zhu, Jin‐an Jiao, Ralitza Zankina, Alex Aller, Peter E. Andreotti	2003	31
17	Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial. PubMed ·Christian M. Kurbacher, Howard W. Bruckner, Ian A. Cree, J.A. Kurbacher, Lindsey B. Wilhelm, G. Pöch, D Indefrei, Peter Mallmann, Peter E. Andreotti	1997	30
18	Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures Anti-Cancer Drugs ·Ian A. Cree, Mario Pazzagli, Enrico Mini, Teresita Mazzei, Elizabeth M. Hunter, Lesley Sutherland, Pamela Pinzani, Alessandra Gerli, Peter E. Andreotti	1995	29
19	In vitro activity of titanocenedichloride versus cisplatin in four ovarian carcinoma cell lines evaluated by a microtiter plate ATP bioluminescence assay Anti-Cancer Drugs ·Christian M. Kurbacher, Howard W. Bruckner, Peter E. Andreotti, J.A. Kurbacher, Gretel Sa, Dieter Krebs	1995	22
20	APPLICATIONS OF TIME‐RESOLVED FLUOROIMMUNOASSAY TO DETECT MAGNETIC BEAD CAPTURED ESCHERICHIA COLI O157:H7 Journal of Rapid Methods & Automation in Microbiology ·Shu‐I Tu, MARSHA GOLDEN, Peter E. Andreotti, Linda Yu, Peter L. Irwin	2001	22

About Peter E. Andreotti

Peter E. Andreotti is a scholar working on Endocrinology, Immunology, Pharmaceutical Science, Oncology and Molecular Biology, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include bioluminescence and chemiluminescence research (9 papers), Biosensors and Analytical Detection (6 papers), T-cell and B-cell Immunology (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers), Salmonella and Campylobacter epidemiology (3 papers), Biosimilars and Bioanalytical Methods (3 papers) and Escherichia coli research studies (3 papers). The work is most often cited by research in Oncology (479 citations), Virology (73 citations), Reproductive Medicine (114 citations), Immunology (255 citations) and Cancer Research (144 citations). Peter E. Andreotti has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Christian M. Kurbacher, Ian A. Cree, Peter Cresswell, Howard W. Bruckner, Dieter Krebs, John Apgar, Uwe Wagner, I A Cree, Michael Untch and J R Dawson. Their work appears in journals such as Anti-Cancer Drugs, Journal of Pharmaceutical Sciences, The Journal of Immunology, Human Immunology and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact